Bolt Biotherapeutics Statistics
Total Valuation
BOLT has a market cap or net worth of $21.69 million. The enterprise value is -$13.81 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BOLT has 38.26 million shares outstanding. The number of shares has increased by 1.02% in one year.
| Current Share Class | 38.26M |
| Shares Outstanding | 38.26M |
| Shares Change (YoY) | +1.02% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 3.98% |
| Owned by Institutions (%) | 24.71% |
| Float | 27.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.22 |
| Forward PS | n/a |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.16, with a Debt / Equity ratio of 0.25.
| Current Ratio | 3.16 |
| Quick Ratio | 2.98 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.99% and return on invested capital (ROIC) is -37.78%.
| Return on Equity (ROE) | -64.99% |
| Return on Assets (ROA) | -31.76% |
| Return on Capital (ROIC) | -37.78% |
| Revenue Per Employee | $97,790 |
| Profits Per Employee | -$650,850 |
| Employee Count | 100 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.68% in the last 52 weeks. The beta is 0.92, so BOLT's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -39.68% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 0.86 |
| Relative Strength Index (RSI) | 33.52 |
| Average Volume (20 Days) | 123,249 |
Short Selling Information
The latest short interest is 65,990, so 0.17% of the outstanding shares have been sold short.
| Short Interest | 65,990 |
| Short Previous Month | 119,446 |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.24% |
| Short Ratio (days to cover) | 0.54 |
Income Statement
In the last 12 months, BOLT had revenue of $9.78 million and -$65.09 million in losses. Loss per share was -$1.71.
| Revenue | 9.78M |
| Gross Profit | -51.76M |
| Operating Income | -72.33M |
| Pretax Income | -63.03M |
| Net Income | -65.09M |
| EBITDA | -70.51M |
| EBIT | -72.33M |
| Loss Per Share | -$1.71 |
Full Income StatementBalance Sheet
The company has $53.80 million in cash and $18.18 million in debt, giving a net cash position of $35.62 million or $0.93 per share.
| Cash & Cash Equivalents | 53.80M |
| Total Debt | 18.18M |
| Net Cash | 35.62M |
| Net Cash Per Share | $0.93 |
| Equity (Book Value) | 72.03M |
| Book Value Per Share | 1.88 |
| Working Capital | 39.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$61.12 million and capital expenditures -$47,000, giving a free cash flow of -$61.17 million.
| Operating Cash Flow | -61.12M |
| Capital Expenditures | -47,000 |
| Free Cash Flow | -61.17M |
| FCF Per Share | -$1.60 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -739.68% |
| Pretax Margin | -665.56% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -557.05% |